Table 2 Histological response to preoperative chemotherapy.

From: Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306

 

Grade 1

Grade 2

Grade 3

Grade 4

NE

Proportion of histological response

AI (n = 63)

41

15

6

0

1

8.6% (6/70) (95% CI: 3.2–17.7%)

GD (n = 66)

42

15

6

2

1

11.0% (8/73) (95% CI: 4.9–20.5%)

  1. Data are n unless noted otherwise.
  2. NE not evaluable, AI Adriamycin plus ifosfamide, GD gemcitabine plus docetaxel, CI confidence interval.